Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. Mostrar más
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.29 | -10.6288929074 | 49.77 | 50 | 40.41 | 1004368 | 43.31509653 | CS |
| 4 | -7.77 | -14.8708133971 | 52.25 | 57.28 | 40.41 | 599196 | 48.32879603 | CS |
| 12 | -6.32 | -12.4409448819 | 50.8 | 57.28 | 40.41 | 622911 | 50.62421964 | CS |
| 26 | 17.48 | 64.7407407407 | 27 | 57.28 | 25.82 | 679704 | 44.02530302 | CS |
| 52 | 4.08 | 10.099009901 | 40.4 | 57.28 | 20.0818 | 675916 | 37.52982123 | CS |
| 156 | 27.02 | 154.753722795 | 17.46 | 57.28 | 10.8001 | 414904 | 29.03277463 | CS |
| 260 | 26.18 | 143.06010929 | 18.3 | 63.69 | 10.8001 | 301757 | 29.16438111 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
